| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945609 | The Annals of Thoracic Surgery | 2005 | 5 Pages |
Abstract
Surgical resection may be a viable option for patients with residual N2 disease after induction chemotherapy, provided an R0 resection can be performed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeffrey L. MD, Robert J. MD, Paul C. MD, Matthew A. BS, David E. MA, Roger MD, Nasser K. MD,